The EU Drug Markets Report 2019 is the third comprehensive overview of illicit drug markets in the European Union by the EMCDDA and Europol. The analysis presented in this report spans numerous topics such as the links between drugs and other crimes, the licit economy and society more generally as well as the processes and players involved in the trade, from production and trafficking to distribution. Taking an evidence-based approach, the report reviews the markets for heroin, cocaine, cannabis, amphetamine, methamphetamine, MDMA and new psychoactive substances. It also provides action points to inform policy development at EU and national level. This publication is an essential reference for law enforcement professionals, policymakers, the academic community and indeed for anyone seeking up-to-date information and analysis on drug markets in Europe.
- INPUD online survey on COVID-19 and people who use drugs data report
- Cost-effective tools to reduce the spread of the hepatitis C virus in people who inject drugs
- Reorienting drug policy in Indonesia: Pathways to the Sustainable Development Goals
- EMCDDA trendspotter briefing: Impact of COVID-19 on patterns of drug use and drug-related harms in Europe
- Cannabis rescheduling: What could it mean for Africa?
- Harm reduction for women in prisons
- Barriers to harm reduction for women who use drugs in South Africa
- Interruption and Innovation - The impact of policy measures during the COVID-19 pandemic on key and vulnerable populations for HIV, tuberculosis and viral hepatitis in Eastern Europe and Central Asia
- Capturing the market: Cannabis regulation in Canada